Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Acrocephalosyndactylia × INCB 54828-101 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Carcinoma, Non-Small-Cell Lung 1 Acrocephalosyndactylia 1

Interventions

pemigatinib 6 infigratinib 3 erdafitinib 2 derazantinib 2 Rogaratinib 2 pembrolizumab 1 lenvatinib 1 exemestane 1 brivanib 1 atezolizumab 1 Rabeprazole 1 Irinotecan 1 INCB 54828-101 1 Gemcitabine 1 Fulvestrant 1 E-3810 1 Drug Combinations 1 Carboplatin 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05253807 2025-08-05

FIGHT-210

Incyte Corporation

Phase 2 Completed

8 enrolled 13 charts

Acrocephalosyndactylia, Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡